 Industry: Fine Chemicals Market Cap: $6.7M |
Synthetech is a fine chemicals company specializing in organic synthesis, biocatalysis and chiral technologies. Synthetech develops and manufactures amino acid derivatives, specialty amino acids, peptide fragments, SPPS resins and proprietary custom chiral intermediates primarily for the pharmaceutical and cosmeceutical industries.
Synthetech's products support the development and manufacture of therapeutic peptides and peptidomimetic small molecule drugs at every stage of a customer's clinical development pipeline; including regulatory starting materials advanced intermediates, and early-phase APIs. Synthetech's domestic and international customer base includes major pharmaceutical and emerging biopharmaceutical companies, as well as contract drug synthesis firms. Synthetech also supplies catalog quantities of specialty amino acids to research institutions, universities and drug discovery firms.
|
 Industry: Healthcare Market Cap: $23.0M |
Osteologix, Inc., a development stage biopharmaceutical company, develops pharmaceutical products for the treatment and prevention of bone and cartilage disorders. The company?s product NB S101 is in clinical development for the treatment of Osteoporosis. It also develops products to treat secondary indications in metabolic bone diseases. The company was founded in 2004 and is headquartered in San Francisco, California.
|
 Industry: Healthcare Market Cap: $2.0M |
Pressure BioSciences, Inc. (PBI) is a publicly traded, early-stage company focused on the development of a novel, enabling technology called Pressure Cycling Technology (PCT). PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels (up to 35,000 psi and greater) to rapidly, repeatedly, and safely control bio-molecular interactions. We currently hold 13 US/5 foreign patents covering multiple applications of PCT, including genomic and proteomic sample preparation, pathogen inactivation, enzyme control, immunodiagnostics, and protein purification. We market the PCT Sample Preparation System, an excellent tool for the extraction of DNA/RNA/proteins/small molecules from a variety of animal/plant/microbe/human cells and tissues.
|
 Industry: Business Services Market Cap: $26.8M |
Planktos, Inc. is a for-profit ecorestoration company based in San Francisco with offices in the European Union and British Columbia. Our primary focus is to restore damaged habitats in the ocean and on land. Through iron-stimulated plankton blooms in the oceans and afforestation projects in Europe, we are able to generate carbon credits. We then sell these offsets to individuals and businesses that are looking to reduce their carbon footprint and lower their impact on climate change. The profits from the sale of these carbon credits finance further ecosystem restoration projects.
|
Special Situation Stocks